Skip to main content
Top
Published in: Emerging Themes in Epidemiology 1/2011

Open Access 01-12-2011 | Methodology

Assessing causal relationships in genomics: From Bradford-Hill criteria to complex gene-environment interactions and directed acyclic graphs

Authors: Sara Geneletti, Valentina Gallo, Miquel Porta, Muin J Khoury, Paolo Vineis

Published in: Emerging Themes in Epidemiology | Issue 1/2011

Login to get access

Abstract

Observational studies of human health and disease (basic, clinical and epidemiological) are vulnerable to methodological problems -such as selection bias and confounding- that make causal inferences problematic. Gene-disease associations are no exception, as they are commonly investigated using observational designs. A rich body of knowledge exists in medicine and epidemiology on the assessment of causal relationships involving personal and environmental causes of disease; it includes seminal causal criteria developed by Austin Bradford Hill and more recently applied directed acyclic graphs (DAGs). However, such knowledge has seldom been applied to assess causal relationships in clinical genetics and genomics, even in studies aimed at making inferences relevant for human health. Conversely, incorporating genetic causal knowledge into clinical and epidemiological causal reasoning is still a largely unexplored area.
As the contribution of genetics to the understanding of disease aetiology becomes more important, causal assessment of genetic and genomic evidence becomes fundamental. The method we develop in this paper provides a simple and rigorous first step towards this goal. The present paper is an example of integrative research, i.e., research that integrates knowledge, data, methods, techniques, and reasoning from multiple disciplines, approaches and levels of analysis to generate knowledge that no discipline alone may achieve.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey SG:Mendelian randomization: using genes as instruments for making causal inferences in epidemiology.Stat Med. 2008, 27: 1133-1163. 10.1002/sim.3034CrossRefPubMed Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey SG:Mendelian randomization: using genes as instruments for making causal inferences in epidemiology.Stat Med. 2008, 27: 1133-1163. 10.1002/sim.3034CrossRefPubMed
2.
go back to reference Ioannidis JP, Boffetta P, Little J, O'Brien TR, Uitterlinden AG, Vineis P, Balding DJ, Chokkalingam A, Dolan SM, Flanders WD, Higgins JP, McCarthy MI, McDermott DH, Page GP, Rebbeck TR, Seminara D, Khoury MJ:Assessment of cumulative evidence on genetic associations: interim guidelines.Int J Epidemiol. 2008, 37: 120-132.CrossRefPubMed Ioannidis JP, Boffetta P, Little J, O'Brien TR, Uitterlinden AG, Vineis P, Balding DJ, Chokkalingam A, Dolan SM, Flanders WD, Higgins JP, McCarthy MI, McDermott DH, Page GP, Rebbeck TR, Seminara D, Khoury MJ:Assessment of cumulative evidence on genetic associations: interim guidelines.Int J Epidemiol. 2008, 37: 120-132.CrossRefPubMed
3.
go back to reference Porta M, ed:A Dictionary of Epidemiology.New York: Oxford University Press;, 5 2008, p. 34-37, 65-66, 82-84, 100-103, 116, 129-130, 152-154, 237-238. Porta M, ed:A Dictionary of Epidemiology.New York: Oxford University Press;, 5 2008, p. 34-37, 65-66, 82-84, 100-103, 116, 129-130, 152-154, 237-238.
4.
go back to reference Greenland S, ed: Evolution of Epidemiologic Ideas. Annotated Readings on Concepts and Methods. Chestnut Hill, MA: Epidemiology Resources; 1987. Greenland S, ed: Evolution of Epidemiologic Ideas. Annotated Readings on Concepts and Methods. Chestnut Hill, MA: Epidemiology Resources; 1987.
5.
go back to reference Morabia A: A History of Epidemiologic Methods and Concepts. Basel: Birkhäuser / Springer; 2004.CrossRef Morabia A: A History of Epidemiologic Methods and Concepts. Basel: Birkhäuser / Springer; 2004.CrossRef
6.
go back to reference Fletcher RH, Fletcher SW: Clinical Epidemiology -the Essentials. Philadelphia: Lippincott Williams & Wilkins;, 4 2005. Fletcher RH, Fletcher SW: Clinical Epidemiology -the Essentials. Philadelphia: Lippincott Williams & Wilkins;, 4 2005.
7.
go back to reference Haynes RB, Sackett DL, Guyatt GH, Tugwell P: Clinical epidemiology. How to do clinical practice research. Philadelphia: Lippincott, Williams & Wilkins;, 3 2006. Haynes RB, Sackett DL, Guyatt GH, Tugwell P: Clinical epidemiology. How to do clinical practice research. Philadelphia: Lippincott, Williams & Wilkins;, 3 2006.
9.
go back to reference Vineis P, Manuguerra M, Kavvoura FK, Guarrera S, Allione A, Rosa F, Di Gregorio A, Polidoro S, Saletta F, Ioannidis JP, Matullo G:A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility.J Natl Cancer Inst. 2009, 101: 24-36.CrossRefPubMed Vineis P, Manuguerra M, Kavvoura FK, Guarrera S, Allione A, Rosa F, Di Gregorio A, Polidoro S, Saletta F, Ioannidis JP, Matullo G:A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility.J Natl Cancer Inst. 2009, 101: 24-36.CrossRefPubMed
10.
go back to reference Maraganore DM, de Andrade M, Elbaz A, Farrer MJ, Ioannidis JP, Krüger R, Rocca WA, Schneider NK, Lesnick TG, Lincoln SJ, Hulihan MM, Aasly JO, Ashizawa T, Chartier-Harlin MC, Checkoway H, Ferrarese C, Hadjigeorgiou G, Hattori N, Kawakami H, Lambert JC, Lynch T, Mellick GD, Papapetropoulos S, Parsian A, Quattrone A, Riess O, Tan EK, Van Broeckhoven C:Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium.Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA. 2006, 296: 661-670. 10.1001/jama.296.6.661CrossRefPubMed Maraganore DM, de Andrade M, Elbaz A, Farrer MJ, Ioannidis JP, Krüger R, Rocca WA, Schneider NK, Lesnick TG, Lincoln SJ, Hulihan MM, Aasly JO, Ashizawa T, Chartier-Harlin MC, Checkoway H, Ferrarese C, Hadjigeorgiou G, Hattori N, Kawakami H, Lambert JC, Lynch T, Mellick GD, Papapetropoulos S, Parsian A, Quattrone A, Riess O, Tan EK, Van Broeckhoven C:Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium.Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA. 2006, 296: 661-670. 10.1001/jama.296.6.661CrossRefPubMed
11.
go back to reference Ioannidis JP, Trikalinos TA, Khoury MJ:Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases.Am J Epidemiol. 2006, 164: 609-614. 10.1093/aje/kwj259CrossRefPubMed Ioannidis JP, Trikalinos TA, Khoury MJ:Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases.Am J Epidemiol. 2006, 164: 609-614. 10.1093/aje/kwj259CrossRefPubMed
12.
go back to reference Yang Q, Khoury MJ, Friedman J, Little J, Flanders WD:How many genes underlie the occurrence of common complex diseases in the population?.Int J Epidemiol. 2005, 34: 1129-1137. 10.1093/ije/dyi130CrossRefPubMed Yang Q, Khoury MJ, Friedman J, Little J, Flanders WD:How many genes underlie the occurrence of common complex diseases in the population?.Int J Epidemiol. 2005, 34: 1129-1137. 10.1093/ije/dyi130CrossRefPubMed
13.
go back to reference Ioannidis JP, Trikalinos TA:Early extreme contradictory estimates may appear in published research: the Proteus phenomenon in molecular genetics research and randomized trials.J Clin Epidemiol. 2005, 58: 543-549. 10.1016/j.jclinepi.2004.10.019CrossRefPubMed Ioannidis JP, Trikalinos TA:Early extreme contradictory estimates may appear in published research: the Proteus phenomenon in molecular genetics research and randomized trials.J Clin Epidemiol. 2005, 58: 543-549. 10.1016/j.jclinepi.2004.10.019CrossRefPubMed
14.
go back to reference Lee DH, Jacobs DR Jr, Porta M:Hypothesis: a unifying mechanism for nutrition and chemicals as lifelong modulators of DNA hypomethylation.Environ Health Perspect. 2009, 117: 1799-1802.PubMedCentralCrossRefPubMed Lee DH, Jacobs DR Jr, Porta M:Hypothesis: a unifying mechanism for nutrition and chemicals as lifelong modulators of DNA hypomethylation.Environ Health Perspect. 2009, 117: 1799-1802.PubMedCentralCrossRefPubMed
15.
go back to reference Glazier AM, Nadeau JH, Aitman TJ:Finding genes that underlie complex traits.Science. 2002, 298: 2345-2349. 10.1126/science.1076641CrossRefPubMed Glazier AM, Nadeau JH, Aitman TJ:Finding genes that underlie complex traits.Science. 2002, 298: 2345-2349. 10.1126/science.1076641CrossRefPubMed
16.
go back to reference Jirtle RL, Skinner MK:Environmental epigenomics and disease susceptibility.Nat Rev Genet. 2007, 8: 253-62. 10.1038/nrg2045CrossRefPubMed Jirtle RL, Skinner MK:Environmental epigenomics and disease susceptibility.Nat Rev Genet. 2007, 8: 253-62. 10.1038/nrg2045CrossRefPubMed
17.
go back to reference Feinberg AP:Phenotypic plasticity and the epigenetics of human disease.Nature. 2007, 447: 433-440. 10.1038/nature05919CrossRefPubMed Feinberg AP:Phenotypic plasticity and the epigenetics of human disease.Nature. 2007, 447: 433-440. 10.1038/nature05919CrossRefPubMed
18.
19.
go back to reference Bellivier F, Henry C, Szöke A, Schürhoff F, Nosten-Bertrand M, Feingold J, Launay JM, Leboyer M, Laplanche JL:Serotonin transporter gene polymorphisms in patients with unipolar or bipolar depression.Neurosci Lett. 1998, 255: 143-146. 10.1016/S0304-3940(98)00677-6CrossRefPubMed Bellivier F, Henry C, Szöke A, Schürhoff F, Nosten-Bertrand M, Feingold J, Launay JM, Leboyer M, Laplanche JL:Serotonin transporter gene polymorphisms in patients with unipolar or bipolar depression.Neurosci Lett. 1998, 255: 143-146. 10.1016/S0304-3940(98)00677-6CrossRefPubMed
20.
go back to reference Kim YI:5, 10-Methylenetetrahydrofolate reductase polymorphisms and pharmacogenetics: a new role of single nucleotide polymorphisms in the folate metabolic pathway in human health and disease.Nutr Rev. 2005, 63: 398-407. 10.1111/j.1753-4887.2005.tb00377.xCrossRefPubMed Kim YI:5, 10-Methylenetetrahydrofolate reductase polymorphisms and pharmacogenetics: a new role of single nucleotide polymorphisms in the folate metabolic pathway in human health and disease.Nutr Rev. 2005, 63: 398-407. 10.1111/j.1753-4887.2005.tb00377.xCrossRefPubMed
21.
go back to reference Neasham D, Gallo V, Guarrera S, Dunning A, Overvad K, Tjonneland A, Clavel-Chapelon F, Linseisen JP, Malaveille C, Ferrari P, Boeing H, Benetou V, Trichopoulou A, Palli D, Crosignani P, Tumino R, Panico S, Bueno de Mesquita HB, Peeters PH, van Gib CH, Lund E, Gonzalez CA, Martinez C, Dorronsoro M, Barricarte A, Navarro C, Quiros JR, Berglund G, Jarvholm B, Khaw KT, et al: Double-strand break DNA repair genotype predictive of later mortality and cancer incidence in a cohort of non-smokers. DNA Repair 2008. Neasham D, Gallo V, Guarrera S, Dunning A, Overvad K, Tjonneland A, Clavel-Chapelon F, Linseisen JP, Malaveille C, Ferrari P, Boeing H, Benetou V, Trichopoulou A, Palli D, Crosignani P, Tumino R, Panico S, Bueno de Mesquita HB, Peeters PH, van Gib CH, Lund E, Gonzalez CA, Martinez C, Dorronsoro M, Barricarte A, Navarro C, Quiros JR, Berglund G, Jarvholm B, Khaw KT, et al: Double-strand break DNA repair genotype predictive of later mortality and cancer incidence in a cohort of non-smokers. DNA Repair 2008.
22.
go back to reference Marcus PM, Vineis P, Rothman N:NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case-control studies conducted in the general population.Pharmacogenetics. 2000, 10: 115-122. 10.1097/00008571-200003000-00003CrossRefPubMed Marcus PM, Vineis P, Rothman N:NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case-control studies conducted in the general population.Pharmacogenetics. 2000, 10: 115-122. 10.1097/00008571-200003000-00003CrossRefPubMed
23.
go back to reference Vineis P, McMichael A:Interplay between heterocyclic amines in cooked meat and metabolic phenotype in the etiology of colon cancer.Cancer Causes Control. 1996, 7: 479-486. 10.1007/BF00052675CrossRefPubMed Vineis P, McMichael A:Interplay between heterocyclic amines in cooked meat and metabolic phenotype in the etiology of colon cancer.Cancer Causes Control. 1996, 7: 479-486. 10.1007/BF00052675CrossRefPubMed
24.
go back to reference Vineis P, Pirastu R:Aromatic amines and cancer.Cancer Causes Control. 1997, 8: 346-355. 10.1023/A:1018453104303CrossRefPubMed Vineis P, Pirastu R:Aromatic amines and cancer.Cancer Causes Control. 1997, 8: 346-355. 10.1023/A:1018453104303CrossRefPubMed
25.
go back to reference Ochs-Balcom HM, Wiesner G, Elston RC:A meta-analysis of the association of N-acetyltransferase 2 gene (NAT2) variants with breast cancer.Am J Epidemiol. 2007, 166: 246-254. 10.1093/aje/kwm066CrossRefPubMed Ochs-Balcom HM, Wiesner G, Elston RC:A meta-analysis of the association of N-acetyltransferase 2 gene (NAT2) variants with breast cancer.Am J Epidemiol. 2007, 166: 246-254. 10.1093/aje/kwm066CrossRefPubMed
26.
go back to reference Borlak J, Reamon-Buettner SM:N-acetyltransferase 2 (NAT2) gene polymorphisms in colon and lung cancer patients.BMC Med Genet. 2006, 7: 58. 10.1186/1471-2350-7-58PubMedCentralCrossRefPubMed Borlak J, Reamon-Buettner SM:N-acetyltransferase 2 (NAT2) gene polymorphisms in colon and lung cancer patients.BMC Med Genet. 2006, 7: 58. 10.1186/1471-2350-7-58PubMedCentralCrossRefPubMed
27.
go back to reference Postmenopausal estrogen use and heart disease. N Engl J Med. 1986, 315: 131-136. Postmenopausal estrogen use and heart disease. N Engl J Med. 1986, 315: 131-136.
28.
go back to reference Vineis P, Anttila S, Benhamou S, Spinola M, Hirvonen A, Kiyohara C, Garte SJ, Puntoni R, Rannug A, Strange RC, Taioli E:Evidence of gene gene interactions in lung carcinogenesis in a large pooled analysis.Carcinogenesis. 2007, 28: 1902-1905. 10.1093/carcin/bgm039CrossRefPubMed Vineis P, Anttila S, Benhamou S, Spinola M, Hirvonen A, Kiyohara C, Garte SJ, Puntoni R, Rannug A, Strange RC, Taioli E:Evidence of gene gene interactions in lung carcinogenesis in a large pooled analysis.Carcinogenesis. 2007, 28: 1902-1905. 10.1093/carcin/bgm039CrossRefPubMed
29.
go back to reference Nicholson SJ, Witherden AS, Hafezparast M, Martin JE, Fisher EM:Mice, the motor system, and human motor neuron pathology.Mamm Genome. 2000, 11: 1041-1052. 10.1007/s003350010205CrossRefPubMed Nicholson SJ, Witherden AS, Hafezparast M, Martin JE, Fisher EM:Mice, the motor system, and human motor neuron pathology.Mamm Genome. 2000, 11: 1041-1052. 10.1007/s003350010205CrossRefPubMed
30.
go back to reference Porta M, Álvarez-Dardet C:How is causal inference practised in the biological sciences?.J Epidemiol Community Healt. 2000, 54: 559-560. 10.1136/jech.54.7.559. 10.1136/jech.54.7.559CrossRef Porta M, Álvarez-Dardet C:How is causal inference practised in the biological sciences?.J Epidemiol Community Healt. 2000, 54: 559-560. 10.1136/jech.54.7.559. 10.1136/jech.54.7.559CrossRef
31.
go back to reference Greenland S, Pearl J, Robins JM:Causal diagrams for epidemiologic research.Epidemiology. 1999, 10: 37-48. 10.1097/00001648-199901000-00008CrossRefPubMed Greenland S, Pearl J, Robins JM:Causal diagrams for epidemiologic research.Epidemiology. 1999, 10: 37-48. 10.1097/00001648-199901000-00008CrossRefPubMed
32.
go back to reference Hernán MA, Robins JM:Instruments for causal inference: an epidemiologist's dream?.Epidemiolog. 2006, 17: 360-372. 10.1097/01.ede.0000222409.00878.37. 10.1097/01.ede.0000222409.00878.37CrossRef Hernán MA, Robins JM:Instruments for causal inference: an epidemiologist's dream?.Epidemiolog. 2006, 17: 360-372. 10.1097/01.ede.0000222409.00878.37. 10.1097/01.ede.0000222409.00878.37CrossRef
33.
go back to reference Hernán MA, Robins JM: Causal Inference. New York: Chapman & Hall/CRC; 2010. Hernán MA, Robins JM: Causal Inference. New York: Chapman & Hall/CRC; 2010.
34.
go back to reference Pearl J: Causality: Models, Reasoning, and Inference. Cambridge, U.K.: Cambridge University Press; 2009.CrossRef Pearl J: Causality: Models, Reasoning, and Inference. Cambridge, U.K.: Cambridge University Press; 2009.CrossRef
35.
go back to reference Dawid AP:Conditional independence in statistical theory.With discussion. J Roy Statist Soc B. 1979, 41: 1-31. Dawid AP:Conditional independence in statistical theory.With discussion. J Roy Statist Soc B. 1979, 41: 1-31.
36.
go back to reference Cartwright N: Nature’s capacities and their measurement. 1989. Cartwright N: Nature’s capacities and their measurement. 1989.
37.
go back to reference Davey SG, Ebrahim S:'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?.Int J Epidemiol. 2003, 32: 1-22. 10.1093/ije/dyg070CrossRef Davey SG, Ebrahim S:'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?.Int J Epidemiol. 2003, 32: 1-22. 10.1093/ije/dyg070CrossRef
38.
go back to reference Dawid AP:Influence diagrams for causal modelling and inference.Intern Statist Rev. 2002, 70: 161-189.CrossRef Dawid AP:Influence diagrams for causal modelling and inference.Intern Statist Rev. 2002, 70: 161-189.CrossRef
39.
go back to reference Didelez V, Sheehan N:Mendelian randomization as an instrumental variable approach to causal inference.Stat Methods Med Res. 2007, 16: 309-330. 10.1177/0962280206077743CrossRefPubMed Didelez V, Sheehan N:Mendelian randomization as an instrumental variable approach to causal inference.Stat Methods Med Res. 2007, 16: 309-330. 10.1177/0962280206077743CrossRefPubMed
40.
go back to reference Chen L, Davey SG, Harbord RM, Lewis SJ:Alcohol intake and blood pressure: a systematic review implementing a Mendelian randomization approach.PLoS Med. 2008, 5: e52. 10.1371/journal.pmed.0050052PubMedCentralCrossRefPubMed Chen L, Davey SG, Harbord RM, Lewis SJ:Alcohol intake and blood pressure: a systematic review implementing a Mendelian randomization approach.PLoS Med. 2008, 5: e52. 10.1371/journal.pmed.0050052PubMedCentralCrossRefPubMed
41.
go back to reference Dawid AP:Causal inference without counterfactuals.J Am Statist Ass. 2000, 95: 407-448. 10.2307/2669377. 10.2307/2669377CrossRef Dawid AP:Causal inference without counterfactuals.J Am Statist Ass. 2000, 95: 407-448. 10.2307/2669377. 10.2307/2669377CrossRef
42.
go back to reference Didelez V, Sheenan N: Mendelian randomisation: why epidemiology needs a formal language for causality. Causality and probability in the sciences College Publications London, London; 2007, ed ?. Didelez V, Sheenan N: Mendelian randomisation: why epidemiology needs a formal language for causality. Causality and probability in the sciences College Publications London, London; 2007, ed ?.
43.
go back to reference Geneletti S:Identifying direct and indirect effects in a non-counterfactual framework.J Roy Stat Soc B. 2007, 69: 199-215. 10.1111/j.1467-9868.2007.00584.x. 10.1111/j.1467-9868.2007.00584.xCrossRef Geneletti S:Identifying direct and indirect effects in a non-counterfactual framework.J Roy Stat Soc B. 2007, 69: 199-215. 10.1111/j.1467-9868.2007.00584.x. 10.1111/j.1467-9868.2007.00584.xCrossRef
44.
go back to reference Lauritzen S: Graphical models. Oxford 1996. Lauritzen S: Graphical models. Oxford 1996.
45.
go back to reference Nelson LM, Tanner CM, Van Den Eeden SK, McGuire V: Neuroepidemiology. Oxford Oxford University Press; 2004.CrossRef Nelson LM, Tanner CM, Van Den Eeden SK, McGuire V: Neuroepidemiology. Oxford Oxford University Press; 2004.CrossRef
46.
go back to reference Kuehn BM:Scientists probe role of genes, environment in Parkinson disease.JAMA. 2006, 295: 1883-1885. 10.1001/jama.295.16.1883CrossRefPubMed Kuehn BM:Scientists probe role of genes, environment in Parkinson disease.JAMA. 2006, 295: 1883-1885. 10.1001/jama.295.16.1883CrossRefPubMed
47.
go back to reference Farrer MJ:Genetics of Parkinson disease: paradigm shifts and future prospects.Nat Rev Genet. 2006, 7: 306-318.CrossRefPubMed Farrer MJ:Genetics of Parkinson disease: paradigm shifts and future prospects.Nat Rev Genet. 2006, 7: 306-318.CrossRefPubMed
48.
go back to reference Clements CM, McNally RS, Conti BJ, Mak TW, Ting JP:DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2.Proc Natl Acad Sci USA. 2006, 103: 15091-15096. 10.1073/pnas.0607260103PubMedCentralCrossRefPubMed Clements CM, McNally RS, Conti BJ, Mak TW, Ting JP:DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2.Proc Natl Acad Sci USA. 2006, 103: 15091-15096. 10.1073/pnas.0607260103PubMedCentralCrossRefPubMed
49.
go back to reference Meulener M, Whitworth AJ, Armstrong-Gold CE, Rizzu P, Heutink P, Wes PD, Pallanck LJ, Bonini NM:Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease.Curr Biol. 2005, 15: 1572-1577. 10.1016/j.cub.2005.07.064CrossRefPubMed Meulener M, Whitworth AJ, Armstrong-Gold CE, Rizzu P, Heutink P, Wes PD, Pallanck LJ, Bonini NM:Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease.Curr Biol. 2005, 15: 1572-1577. 10.1016/j.cub.2005.07.064CrossRefPubMed
50.
go back to reference van Duijn CM, Dekker MC, Bonifati V, Galjaard RJ, Houwing-Duistermaat JJ, Snijders PJ, Testers L, Breedveld GJ, Horstink M, Sandkuijl LA, van Swieten JC, Oostra BA, Heutink P:Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36.Am J Hum Genet. 2001, 69: 629-634. 10.1086/322996PubMedCentralCrossRefPubMed van Duijn CM, Dekker MC, Bonifati V, Galjaard RJ, Houwing-Duistermaat JJ, Snijders PJ, Testers L, Breedveld GJ, Horstink M, Sandkuijl LA, van Swieten JC, Oostra BA, Heutink P:Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36.Am J Hum Genet. 2001, 69: 629-634. 10.1086/322996PubMedCentralCrossRefPubMed
51.
go back to reference Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, Dekker MC, Squitieri F, Ibanez P, Joosse M, van Dongen JW, Vanacore N, van Swieten JC, Brice A, Meco G, van Duijn CM, Oostra BA, Heutink P:Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism.Science. 2003, 299: 256-259. 10.1126/science.1077209CrossRefPubMed Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, Dekker MC, Squitieri F, Ibanez P, Joosse M, van Dongen JW, Vanacore N, van Swieten JC, Brice A, Meco G, van Duijn CM, Oostra BA, Heutink P:Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism.Science. 2003, 299: 256-259. 10.1126/science.1077209CrossRefPubMed
52.
go back to reference Bossy-Wetzel E, Schwarzenbacher R, Lipton SA:Molecular pathways to neurodegeneration.Nat Med. 2004, 10 (Suppl): S2-S9.CrossRefPubMed Bossy-Wetzel E, Schwarzenbacher R, Lipton SA:Molecular pathways to neurodegeneration.Nat Med. 2004, 10 (Suppl): S2-S9.CrossRefPubMed
53.
go back to reference Brown TP, Rumsby PC, Capleton AC, Rushton L, Levy LS:Pesticides and Parkinson's disease-is there a link?.Environ Health Perspect. 2006, 114: 156-164. 10.1289/ehp.8095PubMedCentralCrossRefPubMed Brown TP, Rumsby PC, Capleton AC, Rushton L, Levy LS:Pesticides and Parkinson's disease-is there a link?.Environ Health Perspect. 2006, 114: 156-164. 10.1289/ehp.8095PubMedCentralCrossRefPubMed
54.
go back to reference Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT:Chronic systemic pesticide exposure reproduces features of Parkinson's disease.Nat Neurosci. 2000, 3: 1301-1306. 10.1038/81834CrossRefPubMed Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT:Chronic systemic pesticide exposure reproduces features of Parkinson's disease.Nat Neurosci. 2000, 3: 1301-1306. 10.1038/81834CrossRefPubMed
55.
57.
go back to reference Davey Smith G, Lawlor DA, Harbord R, Timpson N, Day I, Ebrahim S:Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology.PLoS Med. 2007, 4: e352. 10.1371/journal.pmed.0040352CrossRef Davey Smith G, Lawlor DA, Harbord R, Timpson N, Day I, Ebrahim S:Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology.PLoS Med. 2007, 4: e352. 10.1371/journal.pmed.0040352CrossRef
58.
go back to reference Alcaro A, Huber R, Panksepp J:Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective.Brain Res Rev. 2007, 56: 283-321. 10.1016/j.brainresrev.2007.07.014PubMedCentralCrossRefPubMed Alcaro A, Huber R, Panksepp J:Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective.Brain Res Rev. 2007, 56: 283-321. 10.1016/j.brainresrev.2007.07.014PubMedCentralCrossRefPubMed
59.
go back to reference VanderWeele TJ, Robins JM:Directed acyclic graphs, sufficient causes, and the properties of conditioning on a common effect.Am J Epidemiol. 2007, 166: 1096-1104. 10.1093/aje/kwm179CrossRefPubMed VanderWeele TJ, Robins JM:Directed acyclic graphs, sufficient causes, and the properties of conditioning on a common effect.Am J Epidemiol. 2007, 166: 1096-1104. 10.1093/aje/kwm179CrossRefPubMed
60.
go back to reference Quik M:Smoking, nicotine and Parkinson's disease.Trends Neurosci. 2004, 27: 561-568. 10.1016/j.tins.2004.06.008CrossRefPubMed Quik M:Smoking, nicotine and Parkinson's disease.Trends Neurosci. 2004, 27: 561-568. 10.1016/j.tins.2004.06.008CrossRefPubMed
61.
go back to reference VanderWeele TJ, Robins JM:The identification of synergism in the sufficient-component-cause framework.Epidemiology. 2007, 18: 329-339. 10.1097/01.ede.0000260218.66432.88CrossRefPubMed VanderWeele TJ, Robins JM:The identification of synergism in the sufficient-component-cause framework.Epidemiology. 2007, 18: 329-339. 10.1097/01.ede.0000260218.66432.88CrossRefPubMed
62.
go back to reference Bonifati V, Rizzu P, Squitieri F, Krieger E, Vanacore N, van Swieten JC, Brice A, van Duijn CM, Oostra B, Meco G, Heutink P:DJ-1 (PARK7), a novel gene for autosomal recessive, early onset parkinsonism.Neurol Sci. 2003, 24: 159-160. 10.1007/s10072-003-0108-0CrossRefPubMed Bonifati V, Rizzu P, Squitieri F, Krieger E, Vanacore N, van Swieten JC, Brice A, van Duijn CM, Oostra B, Meco G, Heutink P:DJ-1 (PARK7), a novel gene for autosomal recessive, early onset parkinsonism.Neurol Sci. 2003, 24: 159-160. 10.1007/s10072-003-0108-0CrossRefPubMed
63.
go back to reference Hague S, Rogaeva E, Hernandez D, Gulick C, Singleton A, Hanson M, Johnson J, Weiser R, Gallardo M, Ravina B, Gwinn-Hardy K, Crawley A, St George-Hyslop PH, Lang AE, Heutink P, Bonifati V, Hardy J, Singleton A:Early-onset Parkinson's disease caused by a compound heterozygous DJ-1 mutation.Ann Neurol. 2003, 54: 271-274. 10.1002/ana.10663CrossRefPubMed Hague S, Rogaeva E, Hernandez D, Gulick C, Singleton A, Hanson M, Johnson J, Weiser R, Gallardo M, Ravina B, Gwinn-Hardy K, Crawley A, St George-Hyslop PH, Lang AE, Heutink P, Bonifati V, Hardy J, Singleton A:Early-onset Parkinson's disease caused by a compound heterozygous DJ-1 mutation.Ann Neurol. 2003, 54: 271-274. 10.1002/ana.10663CrossRefPubMed
64.
go back to reference Liou HH, Tsai MC, Chen CJ, Jeng JS, Chang YC, Chen SY, Chen RC:Environmental risk factors and Parkinson's disease: a case-control study in Taiwan.Neurology. 1997, 48: 1583-1588.CrossRefPubMed Liou HH, Tsai MC, Chen CJ, Jeng JS, Chang YC, Chen SY, Chen RC:Environmental risk factors and Parkinson's disease: a case-control study in Taiwan.Neurology. 1997, 48: 1583-1588.CrossRefPubMed
65.
go back to reference Petrovitch H, Ross GW, Abbott RD, Sanderson WT, Sharp DS, Tanner CM, Masaki KH, Blanchette PL, Popper JS, Foley D, Launer L, White LR:Plantation work and risk of Parkinson disease in a population-based longitudinal study.Arch Neurol. 2002, 59: 1787-1792. 10.1001/archneur.59.11.1787CrossRefPubMed Petrovitch H, Ross GW, Abbott RD, Sanderson WT, Sharp DS, Tanner CM, Masaki KH, Blanchette PL, Popper JS, Foley D, Launer L, White LR:Plantation work and risk of Parkinson disease in a population-based longitudinal study.Arch Neurol. 2002, 59: 1787-1792. 10.1001/archneur.59.11.1787CrossRefPubMed
66.
go back to reference Hertzman C, Wiens M, Bowering D, Snow B, Calne D:Parkinson's disease: a case-control study of occupational and environmental risk factors.Am J Ind Med. 1990, 17: 349-355. 10.1002/ajim.4700170307CrossRefPubMed Hertzman C, Wiens M, Bowering D, Snow B, Calne D:Parkinson's disease: a case-control study of occupational and environmental risk factors.Am J Ind Med. 1990, 17: 349-355. 10.1002/ajim.4700170307CrossRefPubMed
67.
go back to reference Semchuk KM, Love EJ, Lee RG:Parkinson's disease and exposure to agricultural work and pesticide chemicals.Neurology. 1992, 42: 1328-1335.CrossRefPubMed Semchuk KM, Love EJ, Lee RG:Parkinson's disease and exposure to agricultural work and pesticide chemicals.Neurology. 1992, 42: 1328-1335.CrossRefPubMed
68.
go back to reference Firestone JA, Smith-Weller T, Franklin G, Swanson P, Longstreth WT Jr, Checkoway H: Pesticides and risk of Parkinson disease: a population-based case-control study.Arch Neurol. 2005, 62: 91-95. 10.1001/archneur.62.1.91CrossRefPubMed Firestone JA, Smith-Weller T, Franklin G, Swanson P, Longstreth WT Jr, Checkoway H: Pesticides and risk of Parkinson disease: a population-based case-control study.Arch Neurol. 2005, 62: 91-95. 10.1001/archneur.62.1.91CrossRefPubMed
69.
go back to reference Corasaniti MT, Bagetta G, Rodino P, Gratteri S, Nistico G:Neurotoxic effects induced by intracerebral and systemic injection of paraquat in rats.Hum Exp Toxicol. 1992, 11: 535-539. 10.1177/096032719201100616CrossRefPubMed Corasaniti MT, Bagetta G, Rodino P, Gratteri S, Nistico G:Neurotoxic effects induced by intracerebral and systemic injection of paraquat in rats.Hum Exp Toxicol. 1992, 11: 535-539. 10.1177/096032719201100616CrossRefPubMed
70.
go back to reference Bertrand KA, Spiegelman D, Aster JC, Altshul LM, Korrick SA, Rodig SJ, Zhang SM, Kurth T, Laden F:Plasma organochlorine levels and risk of non-Hodgkin lymphoma in a cohort of men.Epidemiology. 2010, 21: 172-180. 10.1097/EDE.0b013e3181cb610bPubMedCentralCrossRefPubMed Bertrand KA, Spiegelman D, Aster JC, Altshul LM, Korrick SA, Rodig SJ, Zhang SM, Kurth T, Laden F:Plasma organochlorine levels and risk of non-Hodgkin lymphoma in a cohort of men.Epidemiology. 2010, 21: 172-180. 10.1097/EDE.0b013e3181cb610bPubMedCentralCrossRefPubMed
71.
go back to reference Porta M, Pumarega J, López T, Jariod M, Marco E, Grimalt JO:Influence of tumor stage, symptoms and time of blood draw on serum concentrations of organochlorine compounds in exocrine pancreatic cancer.Cancer Causes Contro. 2009, 20: 1893-1906. 10.1007/s10552-009-9383-2. 10.1007/s10552-009-9383-2CrossRef Porta M, Pumarega J, López T, Jariod M, Marco E, Grimalt JO:Influence of tumor stage, symptoms and time of blood draw on serum concentrations of organochlorine compounds in exocrine pancreatic cancer.Cancer Causes Contro. 2009, 20: 1893-1906. 10.1007/s10552-009-9383-2. 10.1007/s10552-009-9383-2CrossRef
72.
go back to reference McCormack AL, Thiruchelvam M, Manning-Bog AB, Thiffault C, Langston JW, Cory-Slechta DA, Di Monte DA:Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat.Neurobiol Dis. 2002, 10: 119-127. 10.1006/nbdi.2002.0507CrossRefPubMed McCormack AL, Thiruchelvam M, Manning-Bog AB, Thiffault C, Langston JW, Cory-Slechta DA, Di Monte DA:Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat.Neurobiol Dis. 2002, 10: 119-127. 10.1006/nbdi.2002.0507CrossRefPubMed
73.
go back to reference Wacholder S, Chatterjee N, Caporaso N:Intermediacy and gene-environment interaction: the example of CHRNA5-A3 region, smoking, nicotine dependence, and lung cancer.J Natl Cancer Inst. 2008, 100: 1488-1491. 10.1093/jnci/djn380PubMedCentralCrossRefPubMed Wacholder S, Chatterjee N, Caporaso N:Intermediacy and gene-environment interaction: the example of CHRNA5-A3 region, smoking, nicotine dependence, and lung cancer.J Natl Cancer Inst. 2008, 100: 1488-1491. 10.1093/jnci/djn380PubMedCentralCrossRefPubMed
75.
go back to reference Susser M: Causal thinking in the health sciences. New York: Oxford University Press; 1973. Susser M: Causal thinking in the health sciences. New York: Oxford University Press; 1973.
76.
go back to reference VanderWeele TJ, Robins JM:Four types of effect modification: a classification based on directed acyclic graphs.Epidemiology. 2007, 18: 561-568. 10.1097/EDE.0b013e318127181bCrossRefPubMed VanderWeele TJ, Robins JM:Four types of effect modification: a classification based on directed acyclic graphs.Epidemiology. 2007, 18: 561-568. 10.1097/EDE.0b013e318127181bCrossRefPubMed
Metadata
Title
Assessing causal relationships in genomics: From Bradford-Hill criteria to complex gene-environment interactions and directed acyclic graphs
Authors
Sara Geneletti
Valentina Gallo
Miquel Porta
Muin J Khoury
Paolo Vineis
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Emerging Themes in Epidemiology / Issue 1/2011
Electronic ISSN: 1742-7622
DOI
https://doi.org/10.1186/1742-7622-8-5

Other articles of this Issue 1/2011

Emerging Themes in Epidemiology 1/2011 Go to the issue